...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Im hoping/believing zen/shares will never sell as cheap as they go for today.

Who knows, im nterested to see where zen ends the day.

If in fact this is the last day to trade them & If something good is actually coming I would expect the sp to reflect that by days end & to be honest I would expect it too close at least the same or higher price point than what the last PP was done at.

 

 

 

Share
New Message
Please login to post a reply